Higher baseline IL-1β, IL-10 and IL-12p70 serum concentrations in NSCLC patients who later developed rheumatic irAE have been independently confirmed in a different patient cohort (personal communication with KB and MMSC). The gene discussed is IL1B; the disease is non-small cell lung carcinoma.